InvestorsHub Logo
Followers 22
Posts 965
Boards Moderated 0
Alias Born 04/23/2012

Re: None

Monday, 02/02/2015 3:01:33 PM

Monday, February 02, 2015 3:01:33 PM

Post# of 57991
Not every R/s ends badly. Ms7p, (musclepharm)did well after a restructuring. They had product and sales and really did it to appeal to institutional investors. If Mely gets product then who knows this may still explode.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.